Filing Details

Accession Number:
0001493152-22-037210
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-30 20:48:50
Reporting Period:
2022-12-29
Accepted Time:
2022-12-30 20:48:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1757499 Shuttle Pharmaceuticals Holdings Inc. SHPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1944900 Peter Dritschilo C/O Shuttle Pharmaceuticals Holdings
One Research Court, Suite 450
Rockville MD 20850
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-29 3,820 $1.61 6,560 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 10,380 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
  2. Consists of 6,560 shares of SHPH common stock.